|
ET-743 (3965 words) |
 | Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study. |
| Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity. |
| Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. |
| H.R. 743, Social Security Protection Act of 2003 (3781 words) |
| H.R. 743 also proposes to extend the attorney-fee system temporarily to SSI, starting nine months after enactment and ending with agreements for representation that are signed five years later. |
| H.R. 743 clarifies that SSA would pay benefits from the trust fund and other costs--for the design, conduct, and evaluation of the demonstrations--from its appropriation for administrative expenses. |
| Under H.R. 743, SSA would split the first SSI check into at least two parts--one for the attorney and one for the beneficiary--as it does in DI. |
Feeds |
Contact